Home › NDC Lookup › RxCUI directory › RxCUI 861015

Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet [Glumetza] — RxCUI 861015

Name: Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet [Glumetza… (RxCUI 861015)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 861015 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861015

Official nameModified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet [Glumetza]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asGlumetza 1000 MG 24HR Extended Release Oral Tablet; Modified 24 HR Glumetza 1000 MG Extended Release Oral Tablet

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)204 prescriptions · 1 state & territory Medicaid programs · latest period Q3 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Metformin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Metformin works in three ways: it lowers the amount of sugar your liver dumps into your bloodstream, slows how much sugar your gut absorbs from food, and helps your body respond to...
What exactly is metformin doing for my diabetes?
Yes, this is very common — diarrhea, nausea, and stomach discomfort are the most frequently reported side effects, and they're often worst when you first start or when your dose go...
My stomach has been a mess since I started metformin. Is that normal? Will it get better?

📖 Read our full Metformin guide →

🕸️ Concept Web — How Modified 24 HR metformin hydrochloride 1000 MG E... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet [Glumetza] RxCUI 861015 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Metformin 6809 IN
- Metformin hydrochloride 235743 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Glumetza 645109 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Metformin Extended Release Oral Tablet 372804 SCDF
- Metformin hydrochloride Extended Release Oral Tablet 2646435 SCDFP
- Metformin Oral Product 1161610 SCDG
- Metformin Pill 1161611 SCDG
- Metformin hydrochloride Oral Product 2662334 SCDGP
- Metformin hydrochloride Pill 2661451 SCDGP
- Metformin Extended Release Oral Tablet [Glumetza] 647241 SBDF
- Metformin hydrochloride Extended Release Oral Tablet [Glumetza] 2656303 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet 1807888 SCD
- Metformin hydrochloride 1000 MG 860995 SCDC
- Metformin hydrochloride 1000 MG [Glumetza] 861014 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Modified 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet SCD · 1807888
Metformin hydrochloride 1000 MG SCDC · 860995
Metformin Extended Release Oral Tablet SCDF · 372804
Metformin hydrochloride Extended Release Oral Tablet SCDFP · 2646435
Metformin Oral Product SCDG · 1161610
Metformin Pill SCDG · 1161611
Metformin hydrochloride Oral Product SCDGP · 2662334
Metformin hydrochloride Pill SCDGP · 2661451

Brand-Name Concepts

Metformin hydrochloride 1000 MG [Glumetza] SBDC · 861014
Metformin Extended Release Oral Tablet [Glumetza] SBDF · 647241
Metformin hydrochloride Extended Release Oral Tablet [Glumetza] SBDFP · 2656303
Glumetza Oral Product SBDG · 1171254
Glumetza Pill SBDG · 1171255
Glumetza BN · 645109

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 861015 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
68012-0002-13	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68012...	Glumetza	Santarus, Inc.	2006-08-01
68012-0003-16	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68012-...	Glumetza	Santarus, Inc.	2008-06-17
68012-0004-50	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68012...	Glumetza	Santarus, Inc.	2018-03-20

Observed labelers: Santarus, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.